sideroblast


Also found in: Dictionary, Medical, Wikipedia.
Related to sideroblast: Myelodysplastic syndrome, ferritin
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to sideroblast

an erythroblast having granules of ferritin

Related Words

References in periodicals archive ?
The myelodysplastic syndromes are characterised by refractory anaemia and ringed sideroblasts, which can transform into a state with excess blasts and then on to acute leukaemia.
In the erythroid lineage, we found significant Megaloblastoid change in a number of cases, but again, did not note other significant dysplastic features such as nuclear budding, multinucleation, or ring sideroblasts.
An appropriate iron stain is needed to demonstrate the distinctive and diagnostically important ringed sideroblasts (Fig.
In 2007, a 60-year-old southern Italian man who presented with severe microcytic anemia, jaundice, hepatosplenomegaly, iron overload, ringed sideroblasts, and cirrhosis was reported (60).
12) As a subgroup of the myelodysplastic syndromes, CMML shares the characteristics of trilineage dysplasia with refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, and refractory anemia with excess blasts in transformation.
Megaloblastoid erythropoiesis with abnormal nuclear division (dyskinesis) and ringed sideroblasts are also present (Slides 5c, 5d, respectively).
VIDAZA is indicated for treatment of patients with the following French-American-British (FAB) myelodysplastic syndrome subtypes: refractory anemia (RA) or refractory anemia with ringed sideroblasts (RARS) (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL).
Decitabine for injection is indicated for the treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups.
6) Cases with an associated myelodysplastic syndrome (SM-MDS) have included refractory anemia with excess blasts types 1 and 2, refractory anemia, refractory anemia with ringed sideroblasts, refractory cytopenia with multilineage dysplasia, and MDS associated with deletion of 5q.
In general, the clinical course of hyperfibrotic MDS or MDS with myelofibrosis is rapidly progressive with short survival, except when myelofibrosis is associated with refractory anemia (RA) or refractory anemia with ring sideroblasts (BARS) subtypes [1,3,4].
London, May 9 (ANI): Scientists have found the gene, called SLC25A38, which causes congenital sideroblastic anaemia-a rare disease mainly characterized by the presence of ringed sideroblasts in the patients' bone marrow.
The patient had a history of myelodysplastic syndrome (refractory anemia with ringed sideroblasts subtype), hypertension, hemochromatosis secondary to repeated transfusions, and coronary artery disease for which he had a four-vessel coronary artery bypass 2 years prior to admission.
These subtypes include: refractory anemia (RA) or refractory anemia with ringed sideroblasts (RARS) if accompanied by neutropenia or thrombocytopenia or requiring transfusions; refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL).
Bone marrow biopsy will reveal decreased sideroblasts and absent stainable iron.
Vidaza is approved for the treatment of patients with some of the French-American-British myelodysplastic syndrome subtypes: refractory anemia or refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocyticleukemia.